Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Olsson

Showing results (501-510 of 632) with videos related to

Pageof 64
Sort By:
European Heart Journal|January 1, 1992
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trialsG Olsson, J Wikstrand, I Warnold, et al.
Antioxidants & Redox Signaling|November 20, 2012
The radical-binding lipocalin A1M binds to a Complex I subunit and protects mitochondrial structure and functionMagnus G Olsson, Lena W Rosenlöf, Heike Kotarsky, et al.
Circulation|July 21, 2004
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) StudyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Antioxidants & Redox Signaling|February 14, 2012
Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α(1)-microglobulinMagnus G Olsson, Maria Allhorn, Leif Bülow, et al.
Journal of Chemical Information and Modeling|February 7, 2012
The hydrogen bond environments of 1H-tetrazole and tetrazolate rings: the structural basis for tetrazole-carboxylic acid bioisosterismFrank H Allen, Colin R Groom, John W Liebeschuetz, et al.
Circulation|September 9, 2004
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trialSotirios Tsimikas, Joseph L Witztum, Elizabeth R Miller, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1993
Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral arteryL Bergstrand, U Erikson, I Holme, et al.
Immunodeficiency|January 1, 1993
The influence of gene duplications in the human immunoglobulin heavy chain constant locus on serum levels of immunoglobulinH Rabbani, A Bottaro, A O Carbonara, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2007
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1991
Gamma globulin prophylaxis to reduce post-transfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypassN al-Khaja, D G Roberts, A Belboul, et al.
Pageof 64

Showing results (501-510 of 632) with videos related to

Sort By:
Pageof 64
European Heart Journal|January 1, 1992
Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trialsG Olsson, J Wikstrand, I Warnold, et al.
Antioxidants & Redox Signaling|November 20, 2012
The radical-binding lipocalin A1M binds to a Complex I subunit and protects mitochondrial structure and functionMagnus G Olsson, Lena W Rosenlöf, Heike Kotarsky, et al.
Circulation|July 21, 2004
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) StudyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Antioxidants & Redox Signaling|February 14, 2012
Pathological conditions involving extracellular hemoglobin: molecular mechanisms, clinical significance, and novel therapeutic opportunities for α(1)-microglobulinMagnus G Olsson, Maria Allhorn, Leif Bülow, et al.
Journal of Chemical Information and Modeling|February 7, 2012
The hydrogen bond environments of 1H-tetrazole and tetrazolate rings: the structural basis for tetrazole-carboxylic acid bioisosterismFrank H Allen, Colin R Groom, John W Liebeschuetz, et al.
Circulation|September 9, 2004
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trialSotirios Tsimikas, Joseph L Witztum, Elizabeth R Miller, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1993
Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral arteryL Bergstrand, U Erikson, I Holme, et al.
Immunodeficiency|January 1, 1993
The influence of gene duplications in the human immunoglobulin heavy chain constant locus on serum levels of immunoglobulinH Rabbani, A Bottaro, A O Carbonara, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 10, 2007
Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1991
Gamma globulin prophylaxis to reduce post-transfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypassN al-Khaja, D G Roberts, A Belboul, et al.
Pageof 64